|
Market Cap | 22.13M | EPS (ttm) | - |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | - | EPS Q/Q | - |
Dividend | - | Sales Q/Q | - |
Insider Own | 68.27% | Inst Own | - |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | - | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 5.35M | 52W Range | 1.70 - 14.49 |
|
|
|
mF International Ltd. is a holding company, which engages in the development and provision of financial trading solutions through its subsidiary. It offers real-time mission critical forex, bullion and commodities trading platform solutions, financial value-added services, mobile applications, and financial information for brokers and institutional clients via internet or platform as software as a service. The company was founded on June 15, 2022 and is headquartered in Hong Kong. |
|
|
|
Market Cap | 647.23M | EPS (ttm) | - |
P/E | - | EPS this Y | 96.35% |
Forward P/E | - | EPS next Y | -22.14% |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | - | EPS Q/Q | - |
Dividend | - | Sales Q/Q | - |
Insider Own | 29.61% | Inst Own | 3.27% |
Insider Trans | 19.27% | Inst Trans | - |
Short Float | 5.13% | Earnings | Mar 26/a |
Analyst Recom | 1.00 | Target Price | 42.75 |
Avg Volume | 493.78K | 52W Range | 15.43 - 35.06 |
|
|
|
Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company. It develops treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
GILEAD SCIENCES, INC. | 10% Owner | Feb 12 '24 | Buy | 22.00 | 910,000 | 20,020,000 | 4,126,119 | Feb 13 05:48 PM | Northpond Ventures III GP, LLC | Former 10% Owner | Feb 12 '24 | Buy | 22.00 | 450,000 | 9,900,000 | 450,000 | Feb 12 05:51 PM | Bain Capital Life Sciences Inv | 10% Owner | Feb 12 '24 | Buy | 22.00 | 450,000 | 9,900,000 | 3,163,868 | Feb 14 05:26 PM | Vida Ventures, LLC | 10% Owner | Feb 12 '24 | Buy | 22.00 | 253,136 | 5,568,992 | 252,553 | Feb 14 07:04 PM |
|
|
|
|
Market Cap | 2.38M | EPS (ttm) | -1.93 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | 0.39 | EPS next 5Y | - |
P/B | 0.52 | EPS Q/Q | 99.48% |
Dividend | - | Sales Q/Q | -50.90% |
Insider Own | 20.98% | Inst Own | 0.69% |
Insider Trans | 0.54% | Inst Trans | 1.74% |
Short Float | 5.53% | Earnings | - |
Analyst Recom | 1.00 | Target Price | 20.00 |
Avg Volume | 5.49M | 52W Range | 0.06 - 2.70 |
|
|
|
Blue Star Foods Corp. is an international seafood company, which processes, imports, packages, and sells refrigerated seafood products. It offers pasteurized crab meat and other seafood products under the Blue Star, Pacifika, Oceanica, Crab and Go Premium Seafood, Lubkin, First Choice, Good Stuff, and Coastal Pride Fresh brands. The company was founded by John Keeler on May 15, 1995 and is headquartered in Miami, FL. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Herian Nubar | Director | Feb 28 '24 | Buy | 0.10 | 21,000 | 2,113 | 224,736 | Mar 14 03:52 PM | Herian Nubar | Director | Jan 16 '24 | Buy | 0.14 | 20,000 | 2,780 | 203,736 | Mar 14 03:52 PM | Herian Nubar | Director | Jan 02 '24 | Buy | 0.15 | 5,000 | 742 | 183,736 | Mar 14 03:52 PM |
|
|
| |
|
Market Cap | 79.16M | EPS (ttm) | 0.18 |
P/E | 20.91 | EPS this Y | -30.56% |
Forward P/E | 8.33 | EPS next Y | 80.00% |
PEG | 1.74 | EPS past 5Y | -25.09% |
P/S | 1.19 | EPS next 5Y | 12.00% |
P/B | 0.51 | EPS Q/Q | -200.86% |
Dividend | 6.40% | Sales Q/Q | -12.58% |
Insider Own | 7.44% | Inst Own | 64.72% |
Insider Trans | 1.71% | Inst Trans | -1.98% |
Short Float | 0.20% | Earnings | Apr 25/a |
Analyst Recom | 2.00 | Target Price | 6.00 |
Avg Volume | 21.55K | 52W Range | 4.12 - 6.57 |
|
|
|
Riverview Bancorp, Inc. operates as a holding company. It provides community banking services to small and medium size businesses, professionals, and individuals. It offers a range of deposit products, including demand deposits, negotiable order of withdrawal accounts, money market accounts, savings accounts, certificates of deposit, and retirement savings plans. The company also provides commercial business, commercial real estate, other real estate mortgage, and real estate construction loans, and consumer loans, such as one-to-four family mortgage loans, home equity lines of credit, land loans, and other secured and unsecured consumer loans. In addition, it is involved in the provision of mortgage brokerage and mortgage loan servicing activities, as well as offering asset management services consisting of trust, estate planning, and investment management services. The company was founded in 1997 and is headquartered in Vancouver, WA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Carlson Bradley | Director | Feb 29 '24 | Buy | 4.70 | 1,021 | 4,799 | 19,421 | Mar 01 07:31 PM | NIES GERALD LEE | Director | Feb 23 '24 | Buy | 4.84 | 22,000 | 106,590 | 190,692 | Feb 27 08:07 PM | Carlson Bradley | Director | Feb 23 '24 | Buy | 4.80 | 1,000 | 4,800 | 18,400 | Feb 23 07:48 PM | Eby Patricia | Director | Feb 22 '24 | Buy | 4.80 | 1,000 | 4,800 | 2,400 | Feb 23 07:42 PM | Graham Stacey | Director | Feb 22 '24 | Buy | 4.75 | 400 | 1,900 | 8,775 | Feb 23 07:34 PM |
|
|
|
|
Market Cap | 3.31M | EPS (ttm) | -10.99 |
P/E | - | EPS this Y | 14.47% |
Forward P/E | - | EPS next Y | 18.46% |
PEG | - | EPS past 5Y | 45.52% |
P/S | 0.37 | EPS next 5Y | - |
P/B | 0.62 | EPS Q/Q | 70.94% |
Dividend | - | Sales Q/Q | -83.07% |
Insider Own | 0.00% | Inst Own | 18.33% |
Insider Trans | - | Inst Trans | - |
Short Float | 1.78% | Earnings | Feb 08/a |
Analyst Recom | 1.00 | Target Price | 45.00 |
Avg Volume | 10.65K | 52W Range | 4.07 - 37.20 |
|
|
|
Applied DNA Sciences, Inc. engages in developing and marketing technologies to produce and detect deoxyribonucleic acid. It operates through the following segments: Therapeutic DNA Production, MDx Testing Services, and DNA Tagging and Security Products and Services. The Therapeutic DNA Production segment offers DNA detection via PCR to provide and develop clinical molecular diagnostics and genetic testing services. The MDx Testing Services segment is involved in performing and developing clinical molecular diagnostic tests and clinical laboratory testing services. The DNA Tagging and Security Products and Services segment includes manufacture and detection of DNA for industrial supply chain security services. The company was founded in 1983 and is headquartered in Stony Brook, NY. |
|
| |
|
Market Cap | 59.47M | EPS (ttm) | 0.13 |
P/E | 10.85 | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | 0.18 | EPS Q/Q | 4012.50% |
Dividend | - | Sales Q/Q | - |
Insider Own | 87.35% | Inst Own | 0.21% |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | 1.72% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 98.17K | 52W Range | 1.55 - 13.27 |
|
|
|
Able View Global, Inc. operates as a brand management company. It offers marketing strategy, branding, digital and social marketing, omni-channel sales, customer service, and overseas logistics. The company is headquartered in Shanghai, China. |
|
|
|
Market Cap | 0.52M | EPS (ttm) | -11.00 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | -75.36% |
P/S | 0.03 | EPS next 5Y | - |
P/B | 0.03 | EPS Q/Q | - |
Dividend | - | Sales Q/Q | - |
Insider Own | 24.02% | Inst Own | 0.30% |
Insider Trans | 0.00% | Inst Trans | -49.48% |
Short Float | 16.69% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 295.24K | 52W Range | 0.56 - 19.45 |
|
|
|
Lion Group Holding Ltd. operates a trading platform that offers a wide spectrum of products and services, including total return service (TRS) trading, contract-for-difference (CFD) trading, insurance brokerage, and futures and securities brokerage. It also owns a SPAC sponsorship team that helps guide private companies through their listing journey while creating value for Lion itself. The company was founded in 2015 and is headquartered in Singapore. |
|
| |
|
Market Cap | 1.80M | EPS (ttm) | -27.02 |
P/E | - | EPS this Y | 49.98% |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | 32.13% |
P/S | 4.27 | EPS next 5Y | - |
P/B | 2.37 | EPS Q/Q | 30.27% |
Dividend | - | Sales Q/Q | - |
Insider Own | 8.89% | Inst Own | 7.12% |
Insider Trans | 7.27% | Inst Trans | - |
Short Float | 3.20% | Earnings | Mar 19/a |
Analyst Recom | 1.00 | Target Price | 11.00 |
Avg Volume | 110.90K | 52W Range | 1.41 - 13.20 |
|
|
|
Cyclacel Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It uses cell cycle, transcriptional regulation and DNA damage response biology to develop medicines for cancer and other proliferative diseases. The company builds a biopharmaceutical business, which is focused in hematology and oncology based on a pipeline of novel drug candidates. Its products include CYC065, seliciclib, and sapacitabine. The company was founded by Ronald J. Berenson, David Philip Lane, and David Glover on August 13, 1996 and is headquartered in Berkeley Heights, NJ. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Rombotis Spiro George | President and CEO | Dec 21 '23 | Buy | 3.31 | 6,070 | 20,122 | 68,658 | Dec 26 04:05 PM | McBarron Paul | See Remarks | Dec 21 '23 | Buy | 3.31 | 1,886 | 6,252 | 33,378 | Dec 26 04:05 PM |
|
|
|
|
Market Cap | 521.77M | EPS (ttm) | - |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | - | EPS Q/Q | - |
Dividend | - | Sales Q/Q | - |
Insider Own | - | Inst Own | 0.00% |
Insider Trans | - | Inst Trans | - |
Short Float | 0.04% | Earnings | Feb 14/b |
Analyst Recom | - | Target Price | - |
Avg Volume | 72.08K | 52W Range | 4.16 - 21.97 |
|
|
|
Nature Wood Group Ltd. is a holding company, which engages in forest management, harvesting and down-stream wood processing and distribution of logs, decking, flooring, and sawn timber products. It operates through the Direct Purchase and ODM, and Manufacturing Segments. The Direct Purchase and ODM segment represent sourcing of live wood and owning designed design on wood products for sales to end customers. The Manufacturing segment is involved in manufacturing decking, flooring, or sawn timbers. The company was founded on September 22, 2011 and is headquartered in Macau, China. |
|
|
|
Market Cap | 2.56M | EPS (ttm) | -1.15 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | 56.27% |
P/S | 0.14 | EPS next 5Y | - |
P/B | 0.41 | EPS Q/Q | -23.26% |
Dividend | 0.00% | Sales Q/Q | -3.99% |
Insider Own | 34.90% | Inst Own | 3.48% |
Insider Trans | 0.00% | Inst Trans | 3.11% |
Short Float | 2.27% | Earnings | Apr 15/a |
Analyst Recom | 1.00 | Target Price | 2.81 |
Avg Volume | 3.02M | 52W Range | 0.14 - 1.35 |
|
|
|
Safe & Green Holdings Corp. is a design and construction services company, which engages in the provision of code engineered cargo shipping containers. It operates through the following segments: Construction, Medical, Development, and Corporate and Support. The Construction Services segment includes the manufacturing of unit SG ECHO and other modules projects. The Medical segment consists of joint venture COVID-19 laboratory operations. The Development segment focuses on real property development. The Corporate and Support segment includes general corporate expenses such as the executive office, corporate finance, accounting, audit, tax, human resources, risk management, information technology, marketing, and legal groups, corporate overhead, and other items not allocated to any of the company's other segments. The company was founded on December 29, 1993 and is headquartered in Miami, FL. |
|
|